December 3, 2025
8:00 am – 6:15 pm
The Hanover Inn
Hanover, NH
REGISTER HERE*
*Please note that registration is required. Space is limited and registration is expected to close on 11/26.
Overview
Clinically-validated Digital therapeutics (DTx) enable real-time insights into a person’s health and provide therapeutic support anytime and anywhere. Science-based DTx greatly improve patient outcomes and dramatically reduce cost of care. DTx are a key vehicle for globally scaling access to effective health care resources and tackling some of our largest challenges in healthcare. And now with the rapid explosion of AI, DTx can be highly dynamic and personalized and promise to radically transform how health care is delivered.
This Digital Health Summit focuses on the evolving scientific, regulatory, policy, payer, industry and implementation landscape of clinically-validated DTx/digital health tools.
This annual event at Dartmouth has become a widely regarded forum focused on innovations in scientific discovery, clinical applications and widespread deployment of DTx.
This Summit will include a discussion of the needs and opportunities in using DTx in extending the reach and impact of behavioral health care; an overview of the global DTx market landscape, including market trends and business models; the promise of the FDA’s new framework for adding software to drug labels; and the promise and challenges of AI-enabled DTx and their associated regulatory considerations.
Additionally, the results of the Phase III CONVOKE study evaluating a novel DTx for experiential negative symptoms of schizophrenia will be presented for the first time in the US at this Summit.
The goal of the dialogue at this Summit is to help shape a vision for how the most effective and engaging digital therapeutics/digital health tools can be widely accessible.
Agenda
8:00 – 8:30 am
Check-In and Breakfast
8:30 – 9 :00 am
Welcome and Opening Remarks
Lisa Marsch, Director, Center for Technology and Behavioral Health, Andrew G Wallace Professor, Departments of Psychiatry and Biomedical Data Science, Geisel School of Medicine, Dartmouth College
9:00 – 9:45 am
Digital Health: Disruption, Distraction, and The Inevitable
Andy Molnar, Senior Vice President and Head of Digital Health, American Telemedicine Association (ATA) and ATA Action
9:45 – 10:15 am
Reimagining Mental Health: The Promise of Digital Therapeutics
Vaile Wright, Senior Director of Health Care Innovation, American Psychological Association
10:15 – 10:45 am
Before We Regulate the Teddy Bear: Using Today’s FDA Tools to Build Transparent, Accountable GenAI Mental-Health Tech
Aubrey Shick, X-FDA; Digital Health | Policy & Product Strategy Consultant, Launch and Logic, LLC
10:45 – 11:00 am
Coffee & Snack Break
11:00 – 11:30 am
CT-155/BI 3972080, A Digital Therapeutic for Negative Symptoms of Schizophrenia: Results of the Phase 3 Study CONVOKE
Cornelia Dorner-Ciossek, Global Brand Head for Prescription Digital Therapeutics (PDT), Boehringer Ingelheim
11:30 – 12:30 pm
Panel Discussion: The Digital Health Marketplace
- Todd Whitehurst, Engineering Development Lead, Digital Health Care, Sanofi
- Masashi Kiyomine, Managing Partner, Kicker Ventures
- Joel Morse, CEO & Co-Founder, Curavit
- Moderator: Chris Hemphill, Founder, Head of Applied Data Science & AI, Modular Feedback
12:30 – 1:30 pm
Lunch
1:30 – 2:30 pm
Panel Discussion: The Promise of PDURS (Prescription Drug Use Related Software)
- Jeffrey Abraham, Partner, Health Advances
- Abhishek Pratap, Executive Director, Global Evidence Lead, Boehringer Ingelheim
- Renan Gutman, Chief Product Officer, Remepy
- Moderator: Brian Flatley, Vice President Consulting Services & US Pharma Client Solutions, S3 Connected Health
2:30 – 3:30 pm
Panel Discussion: Regulation in AI-enabled digital health tools
- Andrew Trister, Chief Medical and Scientific Officer, Verily
- Nicholas Jacobson, Associate Professor, Center for Technology and Behavioral Health, Dartmouth College
- Aubrey Shick, X-FDA; Digital Health | Policy & Product Strategy Consultant, Launch and Logic, LLC
- Moderator: Acacia Parks, VP, Regulatory Compliance & Engineering Services, Avania; Lead Consultant, Liquid Amber
3:30 – 3:45 pm
Coffee break
3:45 – 4:45pm
Snapshot of Innovations in Digital Health at the Center for Technology and Behavioral Health at Dartmouth College
- 3:45 – 4:05 – Paul Barr, Associate Professor, The Dartmouth Institute for Health Policy & Clinical Practice, Dartmouth College
AI Powered Clinic Visit Recordings: The Opportunities and Ethical Perils
- 4:05 – 4:25 – Lisa Marsch, Director, Center for Technology and Behavioral Health, Andrew G Wallace Professor, Departments of Psychiatry and Biomedical Data Science, Geisel School of Medicine, Dartmouth College and Nicholas Jacobson, Associate Professor, Center for Technology and Behavioral Health, Dartmouth College
Evergreen: A Novel AI-enabled Platform to Promote Flourishing in Student Life
- 4:25 – 4:45 – Bethany Solomon, Assistant Vice President for Principal Gifts and Venture Philanthropy, Dartmouth Health and Geisel School of Medicine
Building an Innovative Ecosystem to Drive Impact
4:45 – 4:50 pm
Closing Remarks
Lisa Marsch
4:50 – 6:15 pm
Poster Presentations/Prizes and Reception